GeneBioTech Co. Ltd (086060) — Cash Flow Reinvestment Rate
GeneBioTech Co. Ltd (086060) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩2.11 Billion (capex ₩194.03 Million plus investments ₩-1.91 Billion) from operating cash flow of ₩3.87 Billion. Explore 086060 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GeneBioTech Co. Ltd Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for GeneBioTech Co. Ltd across 11 annual periods. Also explore GeneBioTech Co. Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for GeneBioTech Co. Ltd (2009–2023)
Year-by-year capital reinvestment analysis for GeneBioTech Co. Ltd. For live market cap and broader valuation context, see GeneBioTech Co. Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.83x | ₩6.09 Billion | ₩7.37 Billion | ₩766.93 Million | ▼ -73.0% |
| 2020 | 3.06x | ₩7.63 Billion | ₩2.49 Billion | ₩4.39 Billion | ▲ +216.7% |
| 2018 | 0.97x | ₩5.76 Billion | ₩5.96 Billion | ₩558.47 Million | ▼ -80.2% |
| 2017 | 4.89x | ₩5.54 Billion | ₩1.13 Billion | ₩1.11 Billion | ▲ +1014.3% |
| 2016 | 0.44x | ₩2.33 Billion | ₩5.31 Billion | ₩1.30 Billion | ▲ +3.9% |
| 2015 | 0.42x | ₩1.10 Billion | ₩2.61 Billion | ₩927.06 Million | ▲ +61.1% |
| 2014 | 0.26x | ₩565.10 Million | ₩2.15 Billion | ₩510.55 Million | ▲ +7.2% |
| 2013 | 0.24x | ₩582.01 Million | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.51 Billion | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩693.45 Million | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩229.99 Million | ₩2.68 Billion | ₩229.99 Million | — |